Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours.


Journal

Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 08 06 2018
revised: 23 10 2018
accepted: 03 11 2018
pubmed: 7 12 2018
medline: 27 1 2019
entrez: 7 12 2018
Statut: ppublish

Résumé

To evaluate if a deep learning algorithm can be trained to identify tumour-infiltrating lymphocytes (TILs) in tissue samples of testicular germ cell tumours and to assess whether the TIL counts correlate with relapse status of the patient. TILs were manually annotated in 259 tumour regions from 28 whole-slide images (WSIs) of H&E-stained tissue samples. A deep learning algorithm was trained on half of the regions and tested on the other half. The algorithm was further applied to larger areas of tumour WSIs from 89 patients and correlated with clinicopathological data. A correlation coefficient of 0.89 was achieved when comparing the algorithm with the manual TIL count in the test set of images in which TILs were present (n=47). In the WSI regions from the 89 patient samples, the median TIL density was 1009/mm Deep learning-based image analysis can be used for detecting TILs in testicular germ cell cancer more objectively and it has potential for use as a prognostic marker for disease relapse.

Identifiants

pubmed: 30518631
pii: jclinpath-2018-205328
doi: 10.1136/jclinpath-2018-205328
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-164

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JL and ML are founders and consultants at Fimmic Oy, Helsinki, Finland.

Auteurs

Nina Linder (N)

Institute for Molecular Medicine Finland, HILIFE, University of Helsinki, Helsinki, Finland nina.linder@helsinki.fi.
Department of Women's and Children's Health, International Maternal and Child Health, Uppsala University, Uppsala, Sweden.

Jenny C Taylor (JC)

Wellcome Trust Centre for Human Genetics, University of Oxford and Oxford NIHR Biomedical Research Centre, Oxford, UK.

Richard Colling (R)

Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Robert Pell (R)

Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Edward Alveyn (E)

University of Oxford, Medical School, Oxford, UK.

Johnson Joseph (J)

Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Andrew Protheroe (A)

Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Mikael Lundin (M)

Institute for Molecular Medicine Finland, HILIFE, University of Helsinki, Helsinki, Finland.

Johan Lundin (J)

Institute for Molecular Medicine Finland, HILIFE, University of Helsinki, Helsinki, Finland.
Department of Public Health Sciences, Global Health/IHCAR, Karolinska Institutet, Stockholm, Sweden.

Clare Verrill (C)

Nuffield Department of Surgical Sciences and NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH